Navigating the Early-Stage Biotech Dealmaking Landscape: Your Insight is Crucial

Navigating the Early-Stage Biotech Dealmaking Landscape: Your Insight is Crucial

Published on 14/10/2024
Navigating the Early-Stage Biotech Dealmaking Landscape: Your Insight is Crucial

Biotech dealmaking is largely about building effective relationships, but it can often feel like there are invisible barriers to finding and progressing those relationships.

We have some ideas for a better path forward, but we need your help…

At Probacure (a subsidiary of Probatech Ltd), we’ve helped early-stage biotech companies make hundreds of connections with potential partners and investors.  Our latest initiative is a comprehensive survey designed to shed light on the challenges facing young biotechs (pre-funding to post-Series A). 

In this 10-minute survey, we’re asking leaders of early-stage biotech companies how they approach business development, strategy, and fundraising.  

We’d like to know about the challenges you’ve faced as well as your thoughts on the most important solutions. We’ll also invite a select few respondents for in-depth interviews where we can talk about solutions in more detail.

We’re offering all respondents exclusive early access to the results, a free Pitch Deck Mini-Audit and a chance to win a $250 gift voucher.  This is your chance to make a contribution and be ahead of the curve at the same time.

Take the survey, share your insights, and join us in shaping a better path forward in biotech.

Our Valued Sponsors & Partners